查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855462

动物镇静剂市场：依产品类型、动物类型、应用、通路和最终用户划分－2025-2032年全球预测

Animal Sedative Market by Product Type, Animal Type, Application, Distribution Channel, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，动物镇静剂市场规模将达到 2.5856 亿美元，复合年增长率为 13.94%。

关键市场统计数据
基准年 2024 9102万美元
预计年份：2025年 1.0374亿美元
预测年份 2032 2.5856亿美元
复合年增长率 (%) 13.94%

概述了正在重塑兽医镇静剂选择和使用方式的不断变化的临床需求、监管考虑因素和製剂进步。

随着兽医学的进步与不断变化的临床需求和监管审查相交织，兽用镇静治疗领域正在迅速发展。临床医生寻求能够兼顾各种动物种类和手术操作的疗效和安全性的药物，而饲主和相关人员则要求药物能够产生可预测的行为和生理反应，以支持诊断、外科手术和日常护理。同时，製剂和给药途径的创新正在拓展临床和现场的实际应用选择，凸显了基于实证医学选择和管理镇静药物的重要性。

在此背景下，业界必须兼顾有效镇静通讯协定的需求、动物福利考量、食用动物体内药物残留问题以及兽医服务提供者的营运需求。这一趋势正推动产品采用以数据为中心的策略，产品性能的比较、物流处理以及与多种药物镇痛方案的兼容性等因素日益体现在采购和临床指南中。因此，各市场的製造商、经销商和临床负责人正在调整其策略，以符合从业人员的偏好和监管要求。

现代化临床实践、日益严格的监管以及数位化和供应链创新如何重新定义兽医镇静剂生产商和诊所的成功因素

兽用镇静剂市场格局正再形成，这些变革远不止于产品创新。临床实践正朝着多模式治疗方向发展，将镇静剂与镇痛药和多模态相结合，在保持疗效的同时最大限度地减少药物剂量，并提高安全性和恢復率。同时，监管机构对管制药品和牲畜残留限量的日益关注，促使生产商优化标籤、停药指导和供应链可追溯性，以维持市场准入和临床医生的信任。

技术和营运方面的变革也显而易见。用于剂量计算的数位化工具、用于远距行为评估的远距会诊平台以及电子健康记录，使得镇静通讯协定的实施更加规范一致，并有助于术后监测。同时，透过电子商务通路、整合经销伙伴关係以及温控物流实现的供应链现代化，正在改变产品的可及性，并加快临床应用的速度。总而言之，这些发展正在建构一个生态系统，在这个系统中，临床疗效、法规遵循和物流可靠性对于长期成功都同等重要。

评估关税波动和贸易政策发展如何影响动物镇静剂相关人员的供应链选择、采购行为和长期策略定位。

贸易政策调整和关税变动对兽药采购动态有显着影响。关税会改变到岸成本，促进生产在地化，并影响品牌药和非专利药的选择，尤其对于大宗生产和对温度敏感的镇静剂更是如此。进口关税上涨可能导致经销商和诊所优先选择国产製剂或签订长期合约以规避价格波动风险，这也会影响生产商的市场准入和投资策略。

此外，关税带来的成本压力往往促使供应链多元化。企业可能会探索替代采购管道、转移製造地或重组分销模式，以维持利润率并确保供应的连续性。下游方面，动物保健服务提供者会调整库存政策和临床通讯协定，以反映产品供应和成本的变化。诸如此类的应对措施凸显了积极监测贸易政策和进行情境规划的重要性，这有助于相关人员减轻干扰、维持临床标准，并确保医疗机构能够持续获得必要的镇静剂。

以细分市场主导的洞察，揭示产品类型、动物类型、应用领域和分销管道如何影响临床和商业策略以及最终用户的期望。

对细分市场的深入理解有助于更透彻地洞察产品性能和市场机会。依产品类型划分，我们将重点放在吸入、注射和口服给药方式的不同操作特性和临床医生偏好，输注起效时间、持续时间、给药便利性和监测负担等因素会影响不同环境下的临床应用。根据动物种类，伴侣动物、马科动物和家畜的治疗需求差异显着，导致製剂、剂量指导以及残留和清除问题等方面的优先考虑因素不同，这些都会影响临床方案设计和监管标籤。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在风险较高的马匹手术中，新型长效镇静剂製剂的应用日益增加。
  • 加大对物种特异性镇静剂研究的投入，以最大程度地减少不良反应
  • 将数位化监测整合到小动物镇静方案中以优化剂量
  • 监管政策的变化推动了兽医领域对植物来源镇静剂的需求。
  • 用于伴侣动物微创镇静的扩展型可注射经皮吸收贴片
  • 畜牧管理中对多重止痛镇静疗法的偏好日益增加

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依产品类型分類的动物镇静剂市场

  • 吸入剂
  • 注射
  • 口服

第九章 依动物类型分類的动物镇静剂市场

  • 伴侣动物
  • 马
  • 家畜

第十章 动物镇静剂市场依应用领域划分

  • 行为管理
  • 诊断程序
  • 外科手术

第十一章 动物镇静剂市场及通路

  • 网路药房
    • 製造商网站
    • 第三方网站
  • 零售药房
    • 连锁药局
    • 独立药房
  • 动物诊所
  • 兽医诊所

第十二章：依最终用户分類的动物镇静剂市场

  • 研究所
  • 动物诊所
  • 动物用药品经销商
  • 兽医诊所

第十三章：各地区动物镇静剂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 依类别分類的动物镇静剂市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国动物镇静剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim Animal Health GmbH
    • Ceva Sante Animale SA
    • Vetoquinol SA
    • Virbac SA
    • Dechra Pharmaceuticals Plc
    • Norbrook Laboratories Ltd
    • Heska Corporation
Product Code: MRR-8652FEF459B1

The Animal Sedative Market is projected to grow by USD 258.56 million at a CAGR of 13.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 91.02 million
Estimated Year [2025] USD 103.74 million
Forecast Year [2032] USD 258.56 million
CAGR (%) 13.94%

An overview of changing clinical demands regulatory considerations and formulation advances that are reshaping selection and use of sedative agents across veterinary care settings

The therapeutic and procedural landscape for animal sedatives has evolved rapidly as advances in veterinary practice intersect with shifting clinical expectations and regulatory scrutiny. Clinicians increasingly demand agents that balance efficacy with safety across diverse species and procedures, while owners and institutional stakeholders seek predictable behavioral and physiological responses to support diagnostic, surgical, and routine care. Meanwhile, innovation in formulation and delivery routes has expanded practical options in clinics and field settings, amplifying the importance of evidence-driven selection and stewardship of sedative agents.

Against this backdrop, the industry must reconcile the need for effective sedation protocols with heightened emphasis on animal welfare, drug residue considerations in food-producing species, and the operational imperatives of veterinary service providers. These dynamics are driving a more data-centric approach to product adoption, where comparative performance, handling logistics, and compatibility with multimodal analgesia inform procurement and clinical guidelines. As a result, manufacturers, distributors, and clinical leaders are recalibrating strategies to align with both practitioner preferences and regulatory expectations across markets.

How clinical practice modernization regulatory tightening and digital and supply chain innovations are jointly redefining manufacturer and clinic success factors in veterinary sedation

The market environment for animal sedatives is being reshaped by several transformative shifts that extend beyond simple product innovation. Clinical practice has moved toward multimodal approaches that integrate sedatives with analgesics and anxiolytics to minimize drug doses while preserving efficacy, thereby improving safety margins and recovery profiles. Concurrently, heightened regulatory attention on controlled substances and residue limits in livestock has pressured manufacturers to optimize labeling, withdrawal guidance, and supply chain traceability to maintain market access and clinician confidence.

Technological and operational shifts are also evident. Digital tools for dosing calculations, teleconsultation platforms for remote behavioral assessment, and electronic medical records are enabling more consistent application of sedation protocols and facilitating post-procedure monitoring. In parallel, supply chain modernization-driven by e-commerce channels, integrated distribution partnerships, and temperature-controlled logistics-has altered product availability and the speed of clinical adoption. Taken together, these developments are creating an ecosystem where clinical efficacy, regulatory compliance, and logistical reliability are equally critical for long-term success.

Evaluating how tariff shifts and trade policy developments are influencing supply chain choices procurement behavior and long-term strategic positioning for veterinary sedative stakeholders

Trade policy adjustments and tariff movements have a measurable influence on the procurement dynamics of pharmaceutical supplies used in veterinary practice. Tariffs can change landed costs, incentivize localization of production, and affect the choice between branded and generic products, particularly for high-volume or temperature-sensitive sedatives. When import duties rise, distributors and clinics may prioritize domestically produced formulations or negotiate longer-term contracts to insulate against price volatility, which in turn affects manufacturers' market entry and investment strategies.

In addition, tariff-driven cost pressures often prompt supply chain diversification. Companies may seek alternative sourcing routes, shift manufacturing footprints, or restructure distribution models to maintain margin integrity and ensure continuity of supply. Downstream, veterinary service providers adjust inventory policies and clinical protocols to reflect changes in product availability and cost. These responses emphasize the importance of proactive trade policy monitoring and scenario planning so that stakeholders can mitigate disruption, preserve clinical standards, and sustain access to essential sedative agents across care settings.

Segment-driven insights that clarify how distinct product types animal classes applications and distribution pathways shape clinical choices commercial strategies and end-user expectations

A granular understanding of segmentation deepens insight into product performance and commercial opportunity. Based on Product Type, attention centers on the distinct operational characteristics and clinician preferences for Inhalant, Injectable, and Oral modalities, where considerations such as onset time, duration, ease of administration, and monitoring burden shape clinical adoption across settings. Based on Animal Type, therapeutic demands vary substantially among Companion Animals, Equine, and Livestock, creating divergent priorities in formulation, dosing guidance, and residue or clearance concerns that influence both clinical protocol design and regulatory labeling.

Based on Application, use-case specificity is paramount; Behavioral Management, Diagnostic Procedures, and Surgical Procedures each impose unique efficacy and safety requirements, leading to differentiated product positioning and educational needs. Based on Distribution Channel, the landscape includes Online Pharmacies, Retail Pharmacies, Veterinary Clinics, and Veterinary Hospitals, with Online Pharmacies further delineated into Manufacturer Website and Third-Party Website, and Retail Pharmacies further divided into Chain Pharmacies and Independent Pharmacies, all of which influence purchasing behavior, margin structures, and point-of-care accessibility. Finally, Based on End User, the roles of Research Institutes, Veterinary Clinics, Veterinary Drug Distributors, and Veterinary Hospitals determine demand profiles, procurement cycles, and expectations for technical support and post-sale services.

A cross-regional perspective on how regulatory regimes clinical practice maturity and cultural attitudes across the Americas Europe Middle East & Africa and Asia-Pacific influence product strategies

Regional dynamics continue to shape clinical practice, regulatory frameworks, and commercial models for sedative agents. In the Americas, a mature veterinary infrastructure and strong private clinic networks drive demand for advanced formulations and practice-level services, while regulatory oversight and stakeholder expectations emphasize pharmacovigilance and controlled-substance management. In Europe, Middle East & Africa, heterogeneity is pronounced: regulatory stringency and welfare standards in parts of Europe contrast with developing-market needs across some Middle Eastern and African jurisdictions, which affects access models, pricing strategies, and the pace of clinical guideline harmonization.

In the Asia-Pacific region, rapid expansion of veterinary services, rising pet ownership, and growing investments in livestock production create opportunities for broader adoption of diverse sedative modalities, yet pricing sensitivity and fragmented distribution can limit uptake of higher-cost innovations. Across all regions, local regulatory landscapes, cultural attitudes toward animal care, and the maturity of veterinary education systems play decisive roles in the diffusion of new products and protocols. Consequently, region-specific go-to-market strategies, regulatory engagement plans, and clinician education initiatives are crucial for any organization seeking sustainable presence across these geographies.

Key competitive and partnership trends among manufacturers distributors and clinical stakeholders that are determining product differentiation and go-to-market effectiveness in the sedatives arena

Competitive dynamics in the animal sedative space reflect a mixture of established veterinary pharmaceutical manufacturers and specialized innovators. Industry leaders emphasize robust clinical trial programs, comprehensive safety data, and strong regulatory dossiers to support adoption among veterinarians and institutional purchasers. Concurrently, a cohort of agile players is advancing niche formulations, novel delivery mechanisms, and companion diagnostic tools that aim to differentiate on ease-of-use, safety, and species-specific performance.

Strategic partnerships between manufacturers and distribution networks, as well as alliances with veterinary professional associations and academic centers, are increasingly common to accelerate clinical validation and guideline incorporation. Mergers and selective licensing deals continue to shape the landscape, enabling companies to broaden portfolios and access new geographic channels. For stakeholders, the imperative is to combine scientific rigor with pragmatic commercialization tactics, ensuring that product claims are substantiated, post-market surveillance is robust, and clinician support programs address real-world administration and monitoring challenges.

Actionable strategic priorities for manufacturers distributors and clinical leaders focused on evidence building supply chain resilience regulatory engagement and channel-optimized commercialization

Leaders in the sector should prioritize a balanced agenda that integrates clinical evidence generation, regulatory foresight, and supply chain resilience. Investing in rigorous comparative studies and real-world evidence will strengthen product value propositions and facilitate guideline inclusion. At the same time, proactive regulatory engagement focused on labeling, residue management for food-producing animals, and controlled-substance compliance will reduce market access risk and enhance stakeholder trust. Operationally, establishing diversified manufacturing footprints and contingency sourcing arrangements can mitigate the impact of trade policy changes and tariff volatility.

Commercially, firms should tailor distribution strategies to the channel dynamics identified earlier, ensuring that online and retail pathways complement clinic- and hospital-based access, while providing education and technical support to end users. Collaborative initiatives with veterinary training programs and professional societies can accelerate adoption and standardize protocols. Finally, embedding digital tools for dosing decision support and post-procedure monitoring will improve clinical outcomes and create differentiation, making it easier to demonstrate the practical benefits of specific sedative solutions to both clinicians and institutional purchasers.

A clear explanation of the mixed-methods research approach combining practitioner interviews clinical literature regulatory review and cross-validation to ensure robust and reproducible insights

This analysis synthesizes a mixed-methods approach integrating primary qualitative inputs and rigorous secondary research to ensure comprehensive coverage and verifiable conclusions. Primary research involved structured interviews with practicing veterinarians, clinical pharmacologists, distribution executives, and procurement specialists to capture first-hand perspectives on product performance, procurement constraints, and evolving clinical protocols. These insights were triangulated with secondary sources including peer-reviewed literature, regulatory guidance documents, and product labeling to validate clinical assertions and safety considerations.

Data integrity was reinforced through cross-validation across multiple stakeholder groups and regions, with attention to methodological transparency and reproducibility. Where possible, comparative analyses focused on publicly available clinical data, pharmacokinetic profiles, and regulatory records to support claims about relative advantages and implementation considerations. Limitations include variability in reporting standards across jurisdictions and the evolving nature of regulatory guidance, which the methodology addresses through periodic updates and sensitivity checks to maintain relevance and accuracy over time.

A synthesis of strategic imperatives and practical takeaways that emphasize evidence alignment regulatory preparedness and distribution agility as drivers of durable success

The collective findings underscore a consistent theme: success in the animal sedative domain depends on aligning clinical performance with regulatory compliance and pragmatic distribution practices. Stakeholders must navigate species-specific requirements, application-driven performance expectations, and geographically diverse regulatory regimes while maintaining operational agility that addresses supply chain and tariff-related risks. Integrating evidence generation with clinician education and channel-specific commercialization will be central to driving adoption and ensuring long-term clinical and commercial viability.

Looking ahead, organizations that invest in robust safety and efficacy data, cultivate strategic partnerships across distribution and clinical education networks, and implement flexible supply strategies will be best positioned to respond to changing regulatory and market conditions. In essence, a coordinated approach that marries scientific credibility with practical execution will deliver the greatest benefit to animal health professionals and the animals they serve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of novel long-acting sedative formulations for high-risk equine surgeries
  • 5.2. Rising investment in species-specific sedative research to minimize adverse reactions
  • 5.3. Integration of digital monitoring for dosage optimization in small animal sedation protocols
  • 5.4. Regulatory shifts driving demand for plant-derived sedatives in veterinary practice
  • 5.5. Expansion of injectable transdermal patches for minimally invasive sedation in companion animals
  • 5.6. Growing preference for multimodal analgesia and sedation combinations in livestock management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Sedative Market, by Product Type

  • 8.1. Inhalant
  • 8.2. Injectable
  • 8.3. Oral

9. Animal Sedative Market, by Animal Type

  • 9.1. Companion Animals
  • 9.2. Equine
  • 9.3. Livestock

10. Animal Sedative Market, by Application

  • 10.1. Behavioral Management
  • 10.2. Diagnostic Procedures
  • 10.3. Surgical Procedures

11. Animal Sedative Market, by Distribution Channel

  • 11.1. Online Pharmacies
    • 11.1.1. Manufacturer Website
    • 11.1.2. Third-Party Website
  • 11.2. Retail Pharmacies
    • 11.2.1. Chain Pharmacies
    • 11.2.2. Independent Pharmacies
  • 11.3. Veterinary Clinics
  • 11.4. Veterinary Hospitals

12. Animal Sedative Market, by End User

  • 12.1. Research Institutes
  • 12.2. Veterinary Clinics
  • 12.3. Veterinary Drug Distributors
  • 12.4. Veterinary Hospitals

13. Animal Sedative Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Sedative Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Sedative Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Zoetis Inc.
    • 16.3.2. Merck & Co., Inc.
    • 16.3.3. Elanco Animal Health Incorporated
    • 16.3.4. Boehringer Ingelheim Animal Health GmbH
    • 16.3.5. Ceva Sante Animale S.A.
    • 16.3.6. Vetoquinol S.A.
    • 16.3.7. Virbac S.A.
    • 16.3.8. Dechra Pharmaceuticals Plc
    • 16.3.9. Norbrook Laboratories Ltd
    • 16.3.10. Heska Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL SEDATIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ANIMAL SEDATIVE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ANIMAL SEDATIVE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL SEDATIVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL SEDATIVE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL SEDATIVE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INHALANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY EQUINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY BEHAVIORAL MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY THIRD-PARTY WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY DRUG DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANIMAL SEDATIVE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. GCC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GCC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GCC ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. GCC ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. GCC ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. GCC ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. GCC ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. GCC ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. GCC ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. GCC ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. GCC ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 304. GCC ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 305. GCC ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 306. GCC ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 307. GCC ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. GCC ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS ANIMAL SEDATIVE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. BRICS ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. BRICS ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS ANIMAL SEDATIVE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. BRICS ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 334. BRICS ANIMAL SEDATIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 335. BRICS ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 336. BRICS ANIMAL SEDATIVE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 337. BRICS ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 338. BRICS ANIMAL SEDATIVE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 339. BRICS ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. BRICS ANIMAL SEDATIVE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 341. G7 ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILL